Thromb Haemost 1991; 65(03): 275-279
DOI: 10.1055/s-0038-1648134
DOI: 10.1055/s-0038-1648134
Original Article
Correlation between Baseline Plasminogen Activator Inhibitor Levels and Clinical Outcome during Therapy with Tissue Plasminogen Activator for Acute Myocardial Infarction
David C Sane
The Division of Cardiology, Department of Medicine, Duke University, Durham, NC; the Departments of Medicine and Biochemistry, University of Vermont, Burlington, VT; the Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor; Christ Hospital, Cincinnati; the Riverside Methodist Hospital, Columbus; and the Center for Thrombosis and Vascular Research, University of Leuven, Belgium
,
David C Stump
The Division of Cardiology, Department of Medicine, Duke University, Durham, NC; the Departments of Medicine and Biochemistry, University of Vermont, Burlington, VT; the Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor; Christ Hospital, Cincinnati; the Riverside Methodist Hospital, Columbus; and the Center for Thrombosis and Vascular Research, University of Leuven, Belgium
,
Eric J Topol
The Division of Cardiology, Department of Medicine, Duke University, Durham, NC; the Departments of Medicine and Biochemistry, University of Vermont, Burlington, VT; the Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor; Christ Hospital, Cincinnati; the Riverside Methodist Hospital, Columbus; and the Center for Thrombosis and Vascular Research, University of Leuven, Belgium
,
Kristina N Sigmon
The Division of Cardiology, Department of Medicine, Duke University, Durham, NC; the Departments of Medicine and Biochemistry, University of Vermont, Burlington, VT; the Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor; Christ Hospital, Cincinnati; the Riverside Methodist Hospital, Columbus; and the Center for Thrombosis and Vascular Research, University of Leuven, Belgium
,
Dean J Kereiakes
The Division of Cardiology, Department of Medicine, Duke University, Durham, NC; the Departments of Medicine and Biochemistry, University of Vermont, Burlington, VT; the Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor; Christ Hospital, Cincinnati; the Riverside Methodist Hospital, Columbus; and the Center for Thrombosis and Vascular Research, University of Leuven, Belgium
,
Barry S George
The Division of Cardiology, Department of Medicine, Duke University, Durham, NC; the Departments of Medicine and Biochemistry, University of Vermont, Burlington, VT; the Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor; Christ Hospital, Cincinnati; the Riverside Methodist Hospital, Columbus; and the Center for Thrombosis and Vascular Research, University of Leuven, Belgium
,
Susan J Mantell
The Division of Cardiology, Department of Medicine, Duke University, Durham, NC; the Departments of Medicine and Biochemistry, University of Vermont, Burlington, VT; the Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor; Christ Hospital, Cincinnati; the Riverside Methodist Hospital, Columbus; and the Center for Thrombosis and Vascular Research, University of Leuven, Belgium
,
Elizabeth Macy
The Division of Cardiology, Department of Medicine, Duke University, Durham, NC; the Departments of Medicine and Biochemistry, University of Vermont, Burlington, VT; the Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor; Christ Hospital, Cincinnati; the Riverside Methodist Hospital, Columbus; and the Center for Thrombosis and Vascular Research, University of Leuven, Belgium
,
Désiré Collen
The Division of Cardiology, Department of Medicine, Duke University, Durham, NC; the Departments of Medicine and Biochemistry, University of Vermont, Burlington, VT; the Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor; Christ Hospital, Cincinnati; the Riverside Methodist Hospital, Columbus; and the Center for Thrombosis and Vascular Research, University of Leuven, Belgium
,
Robert M Califf
The Division of Cardiology, Department of Medicine, Duke University, Durham, NC; the Departments of Medicine and Biochemistry, University of Vermont, Burlington, VT; the Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor; Christ Hospital, Cincinnati; the Riverside Methodist Hospital, Columbus; and the Center for Thrombosis and Vascular Research, University of Leuven, Belgium
› Author Affiliations
